Clinical trial
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated…
NCT00239044 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00239044 |
|---|---|
| Title | An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients |
| Official title | An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplant Recipients |
| Intervention type | Drug |
| Interventions | Enteric-coated Mycophenolate sodium (EC-MPS) |
| Enrollment | 40 |
| Start date | Dec 1, 2002 |
| Primary completion | Jul 1, 2005 |
| First posted | Oct 14, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: